Elanco Animal Health Inc. ELAN Pet Health — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Elanco Animal Health Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Elanco Animal Health Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Elanco Animal Health Inc.'s pet health — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Elanco Animal Health Inc.'s pet health — revenue?
- Elanco Animal Health Inc. (ELAN) reported pet health — revenue of $710M in Q1 2026.
- How has Elanco Animal Health Inc.'s pet health — revenue changed year-over-year?
- Elanco Animal Health Inc.'s pet health — revenue increased by 11.8% year-over-year, from $635M to $710M.
- What is the long-term trend for Elanco Animal Health Inc.'s pet health — revenue?
- Over 4 years (2021 to 2025), Elanco Animal Health Inc.'s pet health — revenue has grown at a -0.5% compound annual growth rate (CAGR), from $2.35B to $2.3B.
- What does pet health — revenue mean?
- The total revenue generated from sales of products designed for companion animals.
- How do you interpret pet health — revenue?
- An increase suggests successful product adoption, effective marketing, or expansion in the companion animal market, while a decrease may indicate competitive pressure or reduced consumer spending on pet health.
- How does pet health — revenue compare across companies?
- Comparable to companion animal health segments at other veterinary pharmaceutical companies, where growth is often driven by innovation in parasiticides and chronic disease management.